English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Hepatitis B virus (HBV) infection is a major public health concern. The infection affects over 257 million people across the globe and is responsible for 887,000 deaths from complications such as hepatocellular carcinoma and liver failure (1). Most individuals early in their disease are unaware of their infection (2). There are a number of modifiable and non-modifiable risk factors associated with disease progression such as HBV deoxyribonucleic acid (DNA), gender, age, and alanine aminotransferase (ALT) in some patients (3-5). Antiviral therapy is an effective Original Article

Hepatic steatosis contributes to fibrosis in Asian-American patients with chronic hepatitis B infection